Wells Fargo & Company MN Grows Position in Humana Inc (HUM)

Wells Fargo & Company MN increased its position in shares of Humana Inc (NYSE:HUM) by 11.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 1,842,029 shares of the insurance provider’s stock after buying an additional 188,711 shares during the quarter. Wells Fargo & Company MN’s holdings in Humana were worth $456,951,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the stock. First Trust Advisors LP grew its stake in shares of Humana by 43.2% in the 4th quarter. First Trust Advisors LP now owns 122,293 shares of the insurance provider’s stock valued at $30,337,000 after purchasing an additional 36,874 shares during the last quarter. Public Employees Retirement System of Ohio grew its stake in shares of Humana by 0.9% in the 4th quarter. Public Employees Retirement System of Ohio now owns 99,606 shares of the insurance provider’s stock valued at $24,709,000 after purchasing an additional 905 shares during the last quarter. Sei Investments Co. grew its stake in shares of Humana by 46.1% in the 4th quarter. Sei Investments Co. now owns 76,299 shares of the insurance provider’s stock valued at $18,926,000 after purchasing an additional 24,075 shares during the last quarter. New Mexico Educational Retirement Board grew its stake in shares of Humana by 3.7% in the 4th quarter. New Mexico Educational Retirement Board now owns 13,882 shares of the insurance provider’s stock valued at $3,444,000 after purchasing an additional 500 shares during the last quarter. Finally, Catalyst Capital Advisors LLC purchased a new position in shares of Humana in the 4th quarter valued at approximately $335,000. Hedge funds and other institutional investors own 94.13% of the company’s stock.

Several research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their target price on Humana from $253.00 to $271.00 and gave the company a “neutral” rating in a research note on Monday. ValuEngine downgraded Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Credit Suisse Group assumed coverage on Humana in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $256.00 target price on the stock. Oppenheimer lifted their target price on Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a research note on Thursday, February 8th. Finally, Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $294.00 target price on the stock in a research note on Monday. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Humana has a consensus rating of “Buy” and a consensus price target of $270.47.

In related news, SVP Jody L. Bilney sold 7,054 shares of Humana stock in a transaction on Monday, December 18th. The stock was sold at an average price of $247.89, for a total transaction of $1,748,616.06. Following the completion of the transaction, the senior vice president now directly owns 11,704 shares of the company’s stock, valued at $2,901,304.56. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Timothy S. Huval sold 1,382 shares of Humana stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total value of $340,027.28. Following the transaction, the vice president now directly owns 11,557 shares of the company’s stock, valued at $2,843,484.28. The disclosure for this sale can be found here. Insiders sold a total of 10,115 shares of company stock valued at $2,501,627 over the last three months. Insiders own 0.80% of the company’s stock.

Shares of Humana Inc (NYSE:HUM) opened at $267.47 on Thursday. The company has a quick ratio of 1.61, a current ratio of 1.85 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $36,907.53, a P/E ratio of 16.04, a PEG ratio of 1.45 and a beta of 0.93. Humana Inc has a 1-year low of $203.36 and a 1-year high of $293.35.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, beating the consensus estimate of $2.00 by $0.06. The business had revenue of $13.19 billion during the quarter, compared to analysts’ expectations of $13.14 billion. Humana had a return on equity of 16.13% and a net margin of 4.55%. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period last year, the firm earned $2.34 EPS. sell-side analysts anticipate that Humana Inc will post 13.84 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be issued a $0.50 dividend. This is a boost from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.75%. The ex-dividend date of this dividend is Wednesday, March 28th. Humana’s dividend payout ratio (DPR) is currently 9.59%.

Humana declared that its Board of Directors has initiated a stock repurchase program on Thursday, December 14th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the insurance provider to purchase shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.themarketsdaily.com/2018/02/15/wells-fargo-company-mn-grows-position-in-humana-inc-hum.html.

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply